Innovation Pharmaceuticals Inc (IPIX)

[Pepperchino]

I don't think it is a hint, as it has been stated in many PRs their expectations of anti-inflammatory action. For instance, from their May 26 PR about the start of the trial:

http://cellceutix.com/enrollment-begins-in-cellceutix-phase-2-trial-of-brilacidin-om-to-prevent-oral-mucositis-in-patients-undergoing-chemoradiation/

"Cellceutix’s Brilacidin-OM is structurally very different from any available therapeutics for people suffering the often debilitating effects of oral mucositis. Today’s treatments are typically only minimally effective palliative coatings, rather than prophylactic in nature and do not truly address the underlying cause as the Company believes its drug candidate does. Cellceutix has seen promising evidence as to the anti-biofilm and anti-inflammatory benefits of Brilacidin-OM in laboratory research and this Phase 2 trial is an important step in advancing the clinical development plan for Brilacidin-OM as a new approach to the prevention of oral mucositis. With the 21st Century Cures FDA reform bill receiving unanimous approval from the House Energy and Commerce Committee last week, Cellceutix believes that it is in the right place at the right time with the start of this trial, as well as other novel clinical studies in its pipeline."